Danaher Corp. (DHR), which makes medical devices, has reported second quarter earnings that beat Wall Street forecasts on the top and bottom lines.
The Washington, D.C.-based company reported earnings per share (EPS) of $2.05 U.S. for Q2, which was better than the consensus expectation for earnings of $2 U.S. a share.
Revenue for the quarter ended June 30 came in at $7.16 billion U.S., which also topped Wall Street forecasts of $7.11 billion U.S., according to Refinitiv data.
Danaher has now beat expectations for its earnings per share in four consecutive quarters.
However, despite the latest earnings beat, Danaher’s stock declined 5% in premarket trading after the company reported weaker-than-expected free cash flow.
Danaher said that its Q2 free cash flow amounted to $1.59 billion U.S., which was below consensus analyst forecasts of $1.73 billion U.S.
Prior to the latest decline, the stock of Danaher had fallen 6% over the last 12 months to trade at $257.98 U.S. per share.
